Heart Failure

CardioNerds Case Study: Cardiomyopathy and Infantile Hypertrophic Cardiomyopathy Lead to a Unifying Diagnosis

CardioNerdsCardioNerds | December 18, 2024

The CardioNerds and colleagues review the differential diagnosis for peripartum cardiomyopathy.

The CardioNerds Analyze a Stressful Case of Cardiogenic Shock

CardioNerdsCardioNerds | December 2, 2024

The CardioNerds discuss a case involving a patient who presented with stress cardiomyopathy leading to cardiogenic shock.

FDA Approves Attruby (Acoramidis) for the Treatment of ATTR-CM

Rob DillardAHA 2024: CardioNerds | November 27, 2024

The U.S. FDA recently approved Attruby (acoramidis) for adults with ATTR-CM to reduce cardiovascular death, hospitalization.

Transthyretin Amyloid Cardiomyopathy Exacts Higher Costs and Resource Use Compared to Non-Amyloid Heart Failure

Amit Goyal, MDAHA 2024: CardioNerds | November 26, 2024

A study highlights the significant HCRU and costs associated with ATTR-CM.

Acoramidis Demonstrates Long-Term Benefits in ATTR-CM: Results from the ATTRibute-CM Open-Label Extension

Amit Goyal, MDAHA 2024: CardioNerds | November 26, 2024

Promising long-term outcomes from the ongoing OLE of the ATTRibute-CM trial highlight the efficacy of acoramidis.

Case Study: Wild-Type Transthyretin Cardiac Amyloidosis in the Setting of Familial Hypertrophic Obstructive Cardiomyopathy

Rob DillardAHA 2024: CardioNerds | November 26, 2024

A case study highlights the importance of avoiding anchoring bias in the diagnosis of cardiac amyloidosis.

Expert Interviews on Heart Failure

DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.

Get the latest medical updates and insights straight to your inbox.